China Resources Pharmaceutical Group Limited (China Resources Pharma) filed its monthly return for the period ended 30 June 2026, confirming that the company’s share structure remained unchanged during the month.

The total number of issued ordinary shares stood at 6.28 billion, with no treasury shares held. No new shares were issued, cancelled, or repurchased, and there were no conversions, warrant exercises, or other equity-linked transactions recorded.

Public float continued to meet the Main Board’s 25% minimum requirement at month-end, according to the company’s declaration.

Under the existing share option scheme approved on 12 December 2017, 628.45 million shares remain available for potential future grants. No options were outstanding or exercised as of 30 June 2026, and no funds were raised from option exercises.

The filing was signed by Company Secretary Wan Wing Yi Carol on 02 July 2026.